Back to search

Article

Development and Validation of a Novel Glycolysis-Related Risk Signature for Predicting Survival in Pancreatic Adenocarcinoma

2020-05-22

Abstract excerpt

<title>Abstract</title> <p>Background Pancreatic adenocarcinoma (PAAD) is one of the leading causes of cancer death worldwide. Through data mining, an increasing number of biomarkers have been identified for predicting survival of PAAD. However, the ability of single gene biomarkers to predict patient survival is still insufficient. This study aimed to develop a novel risk signature for predicting survival of PA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
67e88cf4-5fb1-5bb4-bc52-b90f18648d62
DOI
10.21203/rs.3.rs-29859/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development and Validation of a Novel Glycolysis-Related Risk Signature for Predicting Survival in Pancreatic AdenocarcinomaDOI 10.21203/rs.3.rs-29859/v1
Select a neighboring publication to make it the new centre.